Given that EphA4 serves as a cognate receptor of RNase1 in breast cancer, furthering our understanding of EphA4 on T cells is worth pursuing to expand the development of cancer treatments by targeting the RNase1-EphA4 axis in the immune system. This evidence concerns the gene RNASE1 and breast cancer.